Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

The U.S. IPO market seems to be cooling off this week, with no major listing planned. This week, Advanced Biomed (ADVB) is ...

Advanced Biomed Inc. (ADVB) expects to raise $10 million in an initial public offering (IPO) on the week of February 24th, IPO Scoop reports. The company will be issuing 1,900,000 shares at $4.00 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

“The potential inclusion of advanced adenomas in Mainz BioMed’s next generation CRC screening test will represent a transformational advancement in self-administered CRC screening. Precise ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...